tiprankstipranks
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ:ACRV
US Market
Holding ACRV?
Track your performance easily

Acrivon Therapeutics, Inc. (ACRV) Financial Statements

158 Followers

Acrivon Therapeutics, Inc. Financial Overview

Acrivon Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.7; its P/E ratio is -2.41; Acrivon Therapeutics, Inc. is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.67. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -22.44M$ -18.80M$ -17.67M$ -21.05M$ -13.91M
EBITDA$ -22.24M$ -17.92M$ -17.44M$ -20.90M$ -12.58M
Net Income Common Stockholders$ -22.44M$ -18.80M$ -16.49M$ -19.25M$ -13.91M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 187.45M$ 180.54M$ 109.97M$ 127.46M$ 150.95M
Total Assets$ 214.68M$ 230.59M$ 120.52M$ 138.26M$ 160.05M
Total Debt$ 4.01M$ 4.22M$ 4.45M$ 4.64M$ 4.60M
Net Debt$ -183.44M$ -176.32M$ -105.53M$ -122.81M$ -146.35M
Total Liabilities$ 17.79M$ 14.53M$ 12.54M$ 17.07M$ 10.87M
Stockholders Equity$ 196.89M$ 216.06M$ 107.98M$ 121.19M$ 149.18M
Cash Flow-
Free Cash Flow$ -18.31M$ -14.04M$ -17.90M$ -13.52M$ -9.22M
Operating Cash Flow$ -17.32M$ -13.90M$ -17.08M$ -12.37M$ -9.11M
Investing Cash Flow$ 16.01M$ -88.04M$ 5.85M$ 20.54M$ 19.34M
Financing Cash Flow$ -1.50M$ 123.35M$ -172.00K$ -2.01M$ 379.00K
Currency in USD

Acrivon Therapeutics, Inc. Earnings and Revenue History

Acrivon Therapeutics, Inc. Debt to Assets

Acrivon Therapeutics, Inc. Cash Flow

Acrivon Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis